Global Passive Digital Biomarker Market Growth 2026-2032
The global Passive Digital Biomarker market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Passive digital biomarkers are individual biological and behavioral data collected passively (passively) through digital technologies, sensors, and smart devices. These data can include physiological parameters (e.g., heart rate, sleep quality, exercise), behavioral activities (e.g., walking, daily activities), environmental factors (e.g., ambient temperature, air quality), etc.
United States market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Passive Digital Biomarker players cover Pfizer, Philips, Novartis, Johnson & Johnson, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Passive Digital Biomarker Industry Forecast? looks at past sales and reviews total world Passive Digital Biomarker sales in 2025, providing a comprehensive analysis by region and market sector of projected Passive Digital Biomarker sales for 2026 through 2032. With Passive Digital Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Digital Biomarker industry.
This Insight Report provides a comprehensive analysis of the global Passive Digital Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Digital Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Passive Digital Biomarker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Digital Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Digital Biomarker.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Digital Biomarker market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Passive digital biomarkers are individual biological and behavioral data collected passively (passively) through digital technologies, sensors, and smart devices. These data can include physiological parameters (e.g., heart rate, sleep quality, exercise), behavioral activities (e.g., walking, daily activities), environmental factors (e.g., ambient temperature, air quality), etc.
United States market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Passive Digital Biomarker is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Passive Digital Biomarker players cover Pfizer, Philips, Novartis, Johnson & Johnson, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Passive Digital Biomarker Industry Forecast? looks at past sales and reviews total world Passive Digital Biomarker sales in 2025, providing a comprehensive analysis by region and market sector of projected Passive Digital Biomarker sales for 2026 through 2032. With Passive Digital Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Digital Biomarker industry.
This Insight Report provides a comprehensive analysis of the global Passive Digital Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Digital Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Passive Digital Biomarker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Digital Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Digital Biomarker.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Digital Biomarker market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Physiological Parameters Type
- Behavioral Activity Type
- Environmental Factors Type
- Others
- Health Management
- Disease Prevention
- Clinical Diagnosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Philips
- Novartis
- Johnson & Johnson
- GlaxoSmithKline
- GE Healthcare
- Asahi Kasei
- Abbott Laboratories
- Merck
- Bayer
- Sanofi
- Koneksa Health
- Huma Therapeutics
- Roche
- Biogen
- What is the 10-year outlook for the global Passive Digital Biomarker market?
- What factors are driving Passive Digital Biomarker market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Passive Digital Biomarker market opportunities vary by end market size?
- How does Passive Digital Biomarker break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Digital Biomarker Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Passive Digital Biomarker by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Passive Digital Biomarker by Country/Region, 2021, 2025 & 2032
2.2 Passive Digital Biomarker Segment by Type
2.2.1 Physiological Parameters Type
2.2.2 Behavioral Activity Type
2.2.3 Environmental Factors Type
2.2.4 Others
2.2.5 Passive Digital Biomarker Sales by Type
2.2.5.1 Global Passive Digital Biomarker Sales Market Share by Type (2021-2026)
2.2.5.2 Global Passive Digital Biomarker Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Passive Digital Biomarker Sale Price by Type (2021-2026)
2.3 Passive Digital Biomarker Segment by Application
2.3.1 Health Management
2.3.2 Disease Prevention
2.3.3 Clinical Diagnosis
2.3.4 Others
2.3.5 Passive Digital Biomarker Sales by Application
2.3.5.1 Global Passive Digital Biomarker Sale Market Share by Application (2021-2026)
2.3.5.2 Global Passive Digital Biomarker Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Passive Digital Biomarker Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Passive Digital Biomarker Breakdown Data by Company
3.1.1 Global Passive Digital Biomarker Annual Sales by Company (2021-2026)
3.1.2 Global Passive Digital Biomarker Sales Market Share by Company (2021-2026)
3.2 Global Passive Digital Biomarker Annual Revenue by Company (2021-2026)
3.2.1 Global Passive Digital Biomarker Revenue by Company (2021-2026)
3.2.2 Global Passive Digital Biomarker Revenue Market Share by Company (2021-2026)
3.3 Global Passive Digital Biomarker Sale Price by Company
3.4 Key Manufacturers Passive Digital Biomarker Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Digital Biomarker Product Location Distribution
3.4.2 Players Passive Digital Biomarker Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE DIGITAL BIOMARKER BY GEOGRAPHIC REGION
4.1 World Historic Passive Digital Biomarker Market Size by Geographic Region (2021-2026)
4.1.1 Global Passive Digital Biomarker Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Passive Digital Biomarker Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Passive Digital Biomarker Market Size by Country/Region (2021-2026)
4.2.1 Global Passive Digital Biomarker Annual Sales by Country/Region (2021-2026)
4.2.2 Global Passive Digital Biomarker Annual Revenue by Country/Region (2021-2026)
4.3 Americas Passive Digital Biomarker Sales Growth
4.4 APAC Passive Digital Biomarker Sales Growth
4.5 Europe Passive Digital Biomarker Sales Growth
4.6 Middle East & Africa Passive Digital Biomarker Sales Growth
5 AMERICAS
5.1 Americas Passive Digital Biomarker Sales by Country
5.1.1 Americas Passive Digital Biomarker Sales by Country (2021-2026)
5.1.2 Americas Passive Digital Biomarker Revenue by Country (2021-2026)
5.2 Americas Passive Digital Biomarker Sales by Type (2021-2026)
5.3 Americas Passive Digital Biomarker Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Digital Biomarker Sales by Region
6.1.1 APAC Passive Digital Biomarker Sales by Region (2021-2026)
6.1.2 APAC Passive Digital Biomarker Revenue by Region (2021-2026)
6.2 APAC Passive Digital Biomarker Sales by Type (2021-2026)
6.3 APAC Passive Digital Biomarker Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Digital Biomarker by Country
7.1.1 Europe Passive Digital Biomarker Sales by Country (2021-2026)
7.1.2 Europe Passive Digital Biomarker Revenue by Country (2021-2026)
7.2 Europe Passive Digital Biomarker Sales by Type (2021-2026)
7.3 Europe Passive Digital Biomarker Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Digital Biomarker by Country
8.1.1 Middle East & Africa Passive Digital Biomarker Sales by Country (2021-2026)
8.1.2 Middle East & Africa Passive Digital Biomarker Revenue by Country (2021-2026)
8.2 Middle East & Africa Passive Digital Biomarker Sales by Type (2021-2026)
8.3 Middle East & Africa Passive Digital Biomarker Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Digital Biomarker
10.3 Manufacturing Process Analysis of Passive Digital Biomarker
10.4 Industry Chain Structure of Passive Digital Biomarker
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Digital Biomarker Distributors
11.3 Passive Digital Biomarker Customer
12 WORLD FORECAST REVIEW FOR PASSIVE DIGITAL BIOMARKER BY GEOGRAPHIC REGION
12.1 Global Passive Digital Biomarker Market Size Forecast by Region
12.1.1 Global Passive Digital Biomarker Forecast by Region (2027-2032)
12.1.2 Global Passive Digital Biomarker Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Passive Digital Biomarker Forecast by Type (2027-2032)
12.7 Global Passive Digital Biomarker Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Passive Digital Biomarker Product Portfolios and Specifications
13.1.3 Pfizer Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Philips
13.2.1 Philips Company Information
13.2.2 Philips Passive Digital Biomarker Product Portfolios and Specifications
13.2.3 Philips Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Philips Main Business Overview
13.2.5 Philips Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Passive Digital Biomarker Product Portfolios and Specifications
13.3.3 Novartis Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Passive Digital Biomarker Product Portfolios and Specifications
13.4.3 Johnson & Johnson Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Passive Digital Biomarker Product Portfolios and Specifications
13.5.3 GlaxoSmithKline Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 GE Healthcare
13.6.1 GE Healthcare Company Information
13.6.2 GE Healthcare Passive Digital Biomarker Product Portfolios and Specifications
13.6.3 GE Healthcare Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GE Healthcare Main Business Overview
13.6.5 GE Healthcare Latest Developments
13.7 Asahi Kasei
13.7.1 Asahi Kasei Company Information
13.7.2 Asahi Kasei Passive Digital Biomarker Product Portfolios and Specifications
13.7.3 Asahi Kasei Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Asahi Kasei Main Business Overview
13.7.5 Asahi Kasei Latest Developments
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Information
13.8.2 Abbott Laboratories Passive Digital Biomarker Product Portfolios and Specifications
13.8.3 Abbott Laboratories Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Abbott Laboratories Main Business Overview
13.8.5 Abbott Laboratories Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Passive Digital Biomarker Product Portfolios and Specifications
13.9.3 Merck Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Bayer
13.10.1 Bayer Company Information
13.10.2 Bayer Passive Digital Biomarker Product Portfolios and Specifications
13.10.3 Bayer Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bayer Main Business Overview
13.10.5 Bayer Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Passive Digital Biomarker Product Portfolios and Specifications
13.11.3 Sanofi Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
13.12 Koneksa Health
13.12.1 Koneksa Health Company Information
13.12.2 Koneksa Health Passive Digital Biomarker Product Portfolios and Specifications
13.12.3 Koneksa Health Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Koneksa Health Main Business Overview
13.12.5 Koneksa Health Latest Developments
13.13 Huma Therapeutics
13.13.1 Huma Therapeutics Company Information
13.13.2 Huma Therapeutics Passive Digital Biomarker Product Portfolios and Specifications
13.13.3 Huma Therapeutics Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Huma Therapeutics Main Business Overview
13.13.5 Huma Therapeutics Latest Developments
13.14 Roche
13.14.1 Roche Company Information
13.14.2 Roche Passive Digital Biomarker Product Portfolios and Specifications
13.14.3 Roche Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Roche Main Business Overview
13.14.5 Roche Latest Developments
13.15 Biogen
13.15.1 Biogen Company Information
13.15.2 Biogen Passive Digital Biomarker Product Portfolios and Specifications
13.15.3 Biogen Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Biogen Main Business Overview
13.15.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Digital Biomarker Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Passive Digital Biomarker by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Passive Digital Biomarker by Country/Region, 2021, 2025 & 2032
2.2 Passive Digital Biomarker Segment by Type
2.2.1 Physiological Parameters Type
2.2.2 Behavioral Activity Type
2.2.3 Environmental Factors Type
2.2.4 Others
2.2.5 Passive Digital Biomarker Sales by Type
2.2.5.1 Global Passive Digital Biomarker Sales Market Share by Type (2021-2026)
2.2.5.2 Global Passive Digital Biomarker Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Passive Digital Biomarker Sale Price by Type (2021-2026)
2.3 Passive Digital Biomarker Segment by Application
2.3.1 Health Management
2.3.2 Disease Prevention
2.3.3 Clinical Diagnosis
2.3.4 Others
2.3.5 Passive Digital Biomarker Sales by Application
2.3.5.1 Global Passive Digital Biomarker Sale Market Share by Application (2021-2026)
2.3.5.2 Global Passive Digital Biomarker Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Passive Digital Biomarker Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Passive Digital Biomarker Breakdown Data by Company
3.1.1 Global Passive Digital Biomarker Annual Sales by Company (2021-2026)
3.1.2 Global Passive Digital Biomarker Sales Market Share by Company (2021-2026)
3.2 Global Passive Digital Biomarker Annual Revenue by Company (2021-2026)
3.2.1 Global Passive Digital Biomarker Revenue by Company (2021-2026)
3.2.2 Global Passive Digital Biomarker Revenue Market Share by Company (2021-2026)
3.3 Global Passive Digital Biomarker Sale Price by Company
3.4 Key Manufacturers Passive Digital Biomarker Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Digital Biomarker Product Location Distribution
3.4.2 Players Passive Digital Biomarker Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE DIGITAL BIOMARKER BY GEOGRAPHIC REGION
4.1 World Historic Passive Digital Biomarker Market Size by Geographic Region (2021-2026)
4.1.1 Global Passive Digital Biomarker Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Passive Digital Biomarker Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Passive Digital Biomarker Market Size by Country/Region (2021-2026)
4.2.1 Global Passive Digital Biomarker Annual Sales by Country/Region (2021-2026)
4.2.2 Global Passive Digital Biomarker Annual Revenue by Country/Region (2021-2026)
4.3 Americas Passive Digital Biomarker Sales Growth
4.4 APAC Passive Digital Biomarker Sales Growth
4.5 Europe Passive Digital Biomarker Sales Growth
4.6 Middle East & Africa Passive Digital Biomarker Sales Growth
5 AMERICAS
5.1 Americas Passive Digital Biomarker Sales by Country
5.1.1 Americas Passive Digital Biomarker Sales by Country (2021-2026)
5.1.2 Americas Passive Digital Biomarker Revenue by Country (2021-2026)
5.2 Americas Passive Digital Biomarker Sales by Type (2021-2026)
5.3 Americas Passive Digital Biomarker Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Digital Biomarker Sales by Region
6.1.1 APAC Passive Digital Biomarker Sales by Region (2021-2026)
6.1.2 APAC Passive Digital Biomarker Revenue by Region (2021-2026)
6.2 APAC Passive Digital Biomarker Sales by Type (2021-2026)
6.3 APAC Passive Digital Biomarker Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Digital Biomarker by Country
7.1.1 Europe Passive Digital Biomarker Sales by Country (2021-2026)
7.1.2 Europe Passive Digital Biomarker Revenue by Country (2021-2026)
7.2 Europe Passive Digital Biomarker Sales by Type (2021-2026)
7.3 Europe Passive Digital Biomarker Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Digital Biomarker by Country
8.1.1 Middle East & Africa Passive Digital Biomarker Sales by Country (2021-2026)
8.1.2 Middle East & Africa Passive Digital Biomarker Revenue by Country (2021-2026)
8.2 Middle East & Africa Passive Digital Biomarker Sales by Type (2021-2026)
8.3 Middle East & Africa Passive Digital Biomarker Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Digital Biomarker
10.3 Manufacturing Process Analysis of Passive Digital Biomarker
10.4 Industry Chain Structure of Passive Digital Biomarker
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Digital Biomarker Distributors
11.3 Passive Digital Biomarker Customer
12 WORLD FORECAST REVIEW FOR PASSIVE DIGITAL BIOMARKER BY GEOGRAPHIC REGION
12.1 Global Passive Digital Biomarker Market Size Forecast by Region
12.1.1 Global Passive Digital Biomarker Forecast by Region (2027-2032)
12.1.2 Global Passive Digital Biomarker Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Passive Digital Biomarker Forecast by Type (2027-2032)
12.7 Global Passive Digital Biomarker Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Passive Digital Biomarker Product Portfolios and Specifications
13.1.3 Pfizer Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Philips
13.2.1 Philips Company Information
13.2.2 Philips Passive Digital Biomarker Product Portfolios and Specifications
13.2.3 Philips Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Philips Main Business Overview
13.2.5 Philips Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Passive Digital Biomarker Product Portfolios and Specifications
13.3.3 Novartis Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Passive Digital Biomarker Product Portfolios and Specifications
13.4.3 Johnson & Johnson Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Passive Digital Biomarker Product Portfolios and Specifications
13.5.3 GlaxoSmithKline Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 GE Healthcare
13.6.1 GE Healthcare Company Information
13.6.2 GE Healthcare Passive Digital Biomarker Product Portfolios and Specifications
13.6.3 GE Healthcare Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GE Healthcare Main Business Overview
13.6.5 GE Healthcare Latest Developments
13.7 Asahi Kasei
13.7.1 Asahi Kasei Company Information
13.7.2 Asahi Kasei Passive Digital Biomarker Product Portfolios and Specifications
13.7.3 Asahi Kasei Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Asahi Kasei Main Business Overview
13.7.5 Asahi Kasei Latest Developments
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Information
13.8.2 Abbott Laboratories Passive Digital Biomarker Product Portfolios and Specifications
13.8.3 Abbott Laboratories Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Abbott Laboratories Main Business Overview
13.8.5 Abbott Laboratories Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Passive Digital Biomarker Product Portfolios and Specifications
13.9.3 Merck Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Bayer
13.10.1 Bayer Company Information
13.10.2 Bayer Passive Digital Biomarker Product Portfolios and Specifications
13.10.3 Bayer Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bayer Main Business Overview
13.10.5 Bayer Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Passive Digital Biomarker Product Portfolios and Specifications
13.11.3 Sanofi Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
13.12 Koneksa Health
13.12.1 Koneksa Health Company Information
13.12.2 Koneksa Health Passive Digital Biomarker Product Portfolios and Specifications
13.12.3 Koneksa Health Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Koneksa Health Main Business Overview
13.12.5 Koneksa Health Latest Developments
13.13 Huma Therapeutics
13.13.1 Huma Therapeutics Company Information
13.13.2 Huma Therapeutics Passive Digital Biomarker Product Portfolios and Specifications
13.13.3 Huma Therapeutics Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Huma Therapeutics Main Business Overview
13.13.5 Huma Therapeutics Latest Developments
13.14 Roche
13.14.1 Roche Company Information
13.14.2 Roche Passive Digital Biomarker Product Portfolios and Specifications
13.14.3 Roche Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Roche Main Business Overview
13.14.5 Roche Latest Developments
13.15 Biogen
13.15.1 Biogen Company Information
13.15.2 Biogen Passive Digital Biomarker Product Portfolios and Specifications
13.15.3 Biogen Passive Digital Biomarker Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Biogen Main Business Overview
13.15.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Passive Digital Biomarker Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Passive Digital Biomarker Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Physiological Parameters Type
Table 4. Major Players of Behavioral Activity Type
Table 5. Major Players of Environmental Factors Type
Table 6. Major Players of Others
Table 7. Global Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 8. Global Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Table 9. Global Passive Digital Biomarker Revenue by Type (2021-2026) & ($ million)
Table 10. Global Passive Digital Biomarker Revenue Market Share by Type (2021-2026)
Table 11. Global Passive Digital Biomarker Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Passive Digital Biomarker Sale by Application (2021-2026) & (K Units)
Table 13. Global Passive Digital Biomarker Sale Market Share by Application (2021-2026)
Table 14. Global Passive Digital Biomarker Revenue by Application (2021-2026) & ($ million)
Table 15. Global Passive Digital Biomarker Revenue Market Share by Application (2021-2026)
Table 16. Global Passive Digital Biomarker Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Passive Digital Biomarker Sales by Company (2021-2026) & (K Units)
Table 18. Global Passive Digital Biomarker Sales Market Share by Company (2021-2026)
Table 19. Global Passive Digital Biomarker Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Passive Digital Biomarker Revenue Market Share by Company (2021-2026)
Table 21. Global Passive Digital Biomarker Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Passive Digital Biomarker Producing Area Distribution and Sales Area
Table 23. Players Passive Digital Biomarker Products Offered
Table 24. Passive Digital Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Passive Digital Biomarker Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Passive Digital Biomarker Sales Market Share Geographic Region (2021-2026)
Table 29. Global Passive Digital Biomarker Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Passive Digital Biomarker Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Passive Digital Biomarker Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Passive Digital Biomarker Sales Market Share by Country/Region (2021-2026)
Table 33. Global Passive Digital Biomarker Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Passive Digital Biomarker Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 36. Americas Passive Digital Biomarker Sales Market Share by Country (2021-2026)
Table 37. Americas Passive Digital Biomarker Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 39. Americas Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 40. APAC Passive Digital Biomarker Sales by Region (2021-2026) & (K Units)
Table 41. APAC Passive Digital Biomarker Sales Market Share by Region (2021-2026)
Table 42. APAC Passive Digital Biomarker Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 44. APAC Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 45. Europe Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 46. Europe Passive Digital Biomarker Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 48. Europe Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Passive Digital Biomarker
Table 54. Key Market Challenges & Risks of Passive Digital Biomarker
Table 55. Key Industry Trends of Passive Digital Biomarker
Table 56. Passive Digital Biomarker Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Passive Digital Biomarker Distributors List
Table 59. Passive Digital Biomarker Customer List
Table 60. Global Passive Digital Biomarker Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Passive Digital Biomarker Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Passive Digital Biomarker Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Passive Digital Biomarker Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Passive Digital Biomarker Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Passive Digital Biomarker Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Passive Digital Biomarker Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Passive Digital Biomarker Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Passive Digital Biomarker Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Passive Digital Biomarker Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Passive Digital Biomarker Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Passive Digital Biomarker Product Portfolios and Specifications
Table 76. Pfizer Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Philips Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 80. Philips Passive Digital Biomarker Product Portfolios and Specifications
Table 81. Philips Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Philips Main Business
Table 83. Philips Latest Developments
Table 84. Novartis Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Passive Digital Biomarker Product Portfolios and Specifications
Table 86. Novartis Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Johnson & Johnson Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Passive Digital Biomarker Product Portfolios and Specifications
Table 91. Johnson & Johnson Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. GlaxoSmithKline Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Passive Digital Biomarker Product Portfolios and Specifications
Table 96. GlaxoSmithKline Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. GE Healthcare Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 100. GE Healthcare Passive Digital Biomarker Product Portfolios and Specifications
Table 101. GE Healthcare Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. GE Healthcare Main Business
Table 103. GE Healthcare Latest Developments
Table 104. Asahi Kasei Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 105. Asahi Kasei Passive Digital Biomarker Product Portfolios and Specifications
Table 106. Asahi Kasei Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Asahi Kasei Main Business
Table 108. Asahi Kasei Latest Developments
Table 109. Abbott Laboratories Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 110. Abbott Laboratories Passive Digital Biomarker Product Portfolios and Specifications
Table 111. Abbott Laboratories Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Abbott Laboratories Main Business
Table 113. Abbott Laboratories Latest Developments
Table 114. Merck Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck Passive Digital Biomarker Product Portfolios and Specifications
Table 116. Merck Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Bayer Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer Passive Digital Biomarker Product Portfolios and Specifications
Table 121. Bayer Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bayer Main Business
Table 123. Bayer Latest Developments
Table 124. Sanofi Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 125. Sanofi Passive Digital Biomarker Product Portfolios and Specifications
Table 126. Sanofi Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sanofi Main Business
Table 128. Sanofi Latest Developments
Table 129. Koneksa Health Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 130. Koneksa Health Passive Digital Biomarker Product Portfolios and Specifications
Table 131. Koneksa Health Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Koneksa Health Main Business
Table 133. Koneksa Health Latest Developments
Table 134. Huma Therapeutics Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 135. Huma Therapeutics Passive Digital Biomarker Product Portfolios and Specifications
Table 136. Huma Therapeutics Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Huma Therapeutics Main Business
Table 138. Huma Therapeutics Latest Developments
Table 139. Roche Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 140. Roche Passive Digital Biomarker Product Portfolios and Specifications
Table 141. Roche Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Roche Main Business
Table 143. Roche Latest Developments
Table 144. Biogen Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 145. Biogen Passive Digital Biomarker Product Portfolios and Specifications
Table 146. Biogen Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Biogen Main Business
Table 148. Biogen Latest Developments
Table 1. Passive Digital Biomarker Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Passive Digital Biomarker Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Physiological Parameters Type
Table 4. Major Players of Behavioral Activity Type
Table 5. Major Players of Environmental Factors Type
Table 6. Major Players of Others
Table 7. Global Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 8. Global Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Table 9. Global Passive Digital Biomarker Revenue by Type (2021-2026) & ($ million)
Table 10. Global Passive Digital Biomarker Revenue Market Share by Type (2021-2026)
Table 11. Global Passive Digital Biomarker Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Passive Digital Biomarker Sale by Application (2021-2026) & (K Units)
Table 13. Global Passive Digital Biomarker Sale Market Share by Application (2021-2026)
Table 14. Global Passive Digital Biomarker Revenue by Application (2021-2026) & ($ million)
Table 15. Global Passive Digital Biomarker Revenue Market Share by Application (2021-2026)
Table 16. Global Passive Digital Biomarker Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Passive Digital Biomarker Sales by Company (2021-2026) & (K Units)
Table 18. Global Passive Digital Biomarker Sales Market Share by Company (2021-2026)
Table 19. Global Passive Digital Biomarker Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Passive Digital Biomarker Revenue Market Share by Company (2021-2026)
Table 21. Global Passive Digital Biomarker Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Passive Digital Biomarker Producing Area Distribution and Sales Area
Table 23. Players Passive Digital Biomarker Products Offered
Table 24. Passive Digital Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Passive Digital Biomarker Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Passive Digital Biomarker Sales Market Share Geographic Region (2021-2026)
Table 29. Global Passive Digital Biomarker Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Passive Digital Biomarker Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Passive Digital Biomarker Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Passive Digital Biomarker Sales Market Share by Country/Region (2021-2026)
Table 33. Global Passive Digital Biomarker Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Passive Digital Biomarker Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 36. Americas Passive Digital Biomarker Sales Market Share by Country (2021-2026)
Table 37. Americas Passive Digital Biomarker Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 39. Americas Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 40. APAC Passive Digital Biomarker Sales by Region (2021-2026) & (K Units)
Table 41. APAC Passive Digital Biomarker Sales Market Share by Region (2021-2026)
Table 42. APAC Passive Digital Biomarker Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 44. APAC Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 45. Europe Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 46. Europe Passive Digital Biomarker Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 48. Europe Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Passive Digital Biomarker Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Passive Digital Biomarker Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Passive Digital Biomarker Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Passive Digital Biomarker
Table 54. Key Market Challenges & Risks of Passive Digital Biomarker
Table 55. Key Industry Trends of Passive Digital Biomarker
Table 56. Passive Digital Biomarker Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Passive Digital Biomarker Distributors List
Table 59. Passive Digital Biomarker Customer List
Table 60. Global Passive Digital Biomarker Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Passive Digital Biomarker Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Passive Digital Biomarker Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Passive Digital Biomarker Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Passive Digital Biomarker Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Passive Digital Biomarker Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Passive Digital Biomarker Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Passive Digital Biomarker Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Passive Digital Biomarker Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Passive Digital Biomarker Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Passive Digital Biomarker Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Passive Digital Biomarker Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Passive Digital Biomarker Product Portfolios and Specifications
Table 76. Pfizer Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Philips Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 80. Philips Passive Digital Biomarker Product Portfolios and Specifications
Table 81. Philips Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Philips Main Business
Table 83. Philips Latest Developments
Table 84. Novartis Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Passive Digital Biomarker Product Portfolios and Specifications
Table 86. Novartis Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Johnson & Johnson Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Passive Digital Biomarker Product Portfolios and Specifications
Table 91. Johnson & Johnson Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. GlaxoSmithKline Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Passive Digital Biomarker Product Portfolios and Specifications
Table 96. GlaxoSmithKline Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. GE Healthcare Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 100. GE Healthcare Passive Digital Biomarker Product Portfolios and Specifications
Table 101. GE Healthcare Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. GE Healthcare Main Business
Table 103. GE Healthcare Latest Developments
Table 104. Asahi Kasei Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 105. Asahi Kasei Passive Digital Biomarker Product Portfolios and Specifications
Table 106. Asahi Kasei Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Asahi Kasei Main Business
Table 108. Asahi Kasei Latest Developments
Table 109. Abbott Laboratories Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 110. Abbott Laboratories Passive Digital Biomarker Product Portfolios and Specifications
Table 111. Abbott Laboratories Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Abbott Laboratories Main Business
Table 113. Abbott Laboratories Latest Developments
Table 114. Merck Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck Passive Digital Biomarker Product Portfolios and Specifications
Table 116. Merck Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Bayer Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer Passive Digital Biomarker Product Portfolios and Specifications
Table 121. Bayer Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bayer Main Business
Table 123. Bayer Latest Developments
Table 124. Sanofi Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 125. Sanofi Passive Digital Biomarker Product Portfolios and Specifications
Table 126. Sanofi Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sanofi Main Business
Table 128. Sanofi Latest Developments
Table 129. Koneksa Health Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 130. Koneksa Health Passive Digital Biomarker Product Portfolios and Specifications
Table 131. Koneksa Health Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Koneksa Health Main Business
Table 133. Koneksa Health Latest Developments
Table 134. Huma Therapeutics Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 135. Huma Therapeutics Passive Digital Biomarker Product Portfolios and Specifications
Table 136. Huma Therapeutics Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Huma Therapeutics Main Business
Table 138. Huma Therapeutics Latest Developments
Table 139. Roche Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 140. Roche Passive Digital Biomarker Product Portfolios and Specifications
Table 141. Roche Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Roche Main Business
Table 143. Roche Latest Developments
Table 144. Biogen Basic Information, Passive Digital Biomarker Manufacturing Base, Sales Area and Its Competitors
Table 145. Biogen Passive Digital Biomarker Product Portfolios and Specifications
Table 146. Biogen Passive Digital Biomarker Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Biogen Main Business
Table 148. Biogen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Passive Digital Biomarker
Figure 2. Passive Digital Biomarker Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Digital Biomarker Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Passive Digital Biomarker Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Passive Digital Biomarker Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Passive Digital Biomarker Sales Market Share by Country/Region (2025)
Figure 10. Passive Digital Biomarker Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Physiological Parameters Type
Figure 12. Product Picture of Behavioral Activity Type
Figure 13. Product Picture of Environmental Factors Type
Figure 14. Product Picture of Others
Figure 15. Global Passive Digital Biomarker Sales Market Share by Type in 2026
Figure 16. Global Passive Digital Biomarker Revenue Market Share by Type (2021-2026)
Figure 17. Passive Digital Biomarker Consumed in Health Management
Figure 18. Global Passive Digital Biomarker Market: Health Management (2021-2026) & (K Units)
Figure 19. Passive Digital Biomarker Consumed in Disease Prevention
Figure 20. Global Passive Digital Biomarker Market: Disease Prevention (2021-2026) & (K Units)
Figure 21. Passive Digital Biomarker Consumed in Clinical Diagnosis
Figure 22. Global Passive Digital Biomarker Market: Clinical Diagnosis (2021-2026) & (K Units)
Figure 23. Passive Digital Biomarker Consumed in Others
Figure 24. Global Passive Digital Biomarker Market: Others (2021-2026) & (K Units)
Figure 25. Global Passive Digital Biomarker Sale Market Share by Application (2025)
Figure 26. Global Passive Digital Biomarker Revenue Market Share by Application in 2026
Figure 27. Passive Digital Biomarker Sales by Company in 2026 (K Units)
Figure 28. Global Passive Digital Biomarker Sales Market Share by Company in 2026
Figure 29. Passive Digital Biomarker Revenue by Company in 2026 ($ millions)
Figure 30. Global Passive Digital Biomarker Revenue Market Share by Company in 2026
Figure 31. Global Passive Digital Biomarker Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Passive Digital Biomarker Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 34. Americas Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 35. APAC Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 36. APAC Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 37. Europe Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 38. Europe Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 41. Americas Passive Digital Biomarker Sales Market Share by Country in 2026
Figure 42. Americas Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Figure 43. Americas Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 44. Americas Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 45. United States Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Passive Digital Biomarker Sales Market Share by Region in 2026
Figure 50. APAC Passive Digital Biomarker Revenue Market Share by Region (2021-2026)
Figure 51. APAC Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 52. APAC Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 53. China Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 57. India Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Passive Digital Biomarker Sales Market Share by Country in 2026
Figure 61. Europe Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Figure 62. Europe Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 63. Europe Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 64. Germany Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 65. France Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Passive Digital Biomarker Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 72. Egypt Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Passive Digital Biomarker in 2026
Figure 78. Manufacturing Process Analysis of Passive Digital Biomarker
Figure 79. Industry Chain Structure of Passive Digital Biomarker
Figure 80. Channels of Distribution
Figure 81. Global Passive Digital Biomarker Sales Market Forecast by Region (2027-2032)
Figure 82. Global Passive Digital Biomarker Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Passive Digital Biomarker Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Passive Digital Biomarker Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Passive Digital Biomarker Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Passive Digital Biomarker Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Passive Digital Biomarker
Figure 2. Passive Digital Biomarker Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Digital Biomarker Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Passive Digital Biomarker Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Passive Digital Biomarker Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Passive Digital Biomarker Sales Market Share by Country/Region (2025)
Figure 10. Passive Digital Biomarker Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Physiological Parameters Type
Figure 12. Product Picture of Behavioral Activity Type
Figure 13. Product Picture of Environmental Factors Type
Figure 14. Product Picture of Others
Figure 15. Global Passive Digital Biomarker Sales Market Share by Type in 2026
Figure 16. Global Passive Digital Biomarker Revenue Market Share by Type (2021-2026)
Figure 17. Passive Digital Biomarker Consumed in Health Management
Figure 18. Global Passive Digital Biomarker Market: Health Management (2021-2026) & (K Units)
Figure 19. Passive Digital Biomarker Consumed in Disease Prevention
Figure 20. Global Passive Digital Biomarker Market: Disease Prevention (2021-2026) & (K Units)
Figure 21. Passive Digital Biomarker Consumed in Clinical Diagnosis
Figure 22. Global Passive Digital Biomarker Market: Clinical Diagnosis (2021-2026) & (K Units)
Figure 23. Passive Digital Biomarker Consumed in Others
Figure 24. Global Passive Digital Biomarker Market: Others (2021-2026) & (K Units)
Figure 25. Global Passive Digital Biomarker Sale Market Share by Application (2025)
Figure 26. Global Passive Digital Biomarker Revenue Market Share by Application in 2026
Figure 27. Passive Digital Biomarker Sales by Company in 2026 (K Units)
Figure 28. Global Passive Digital Biomarker Sales Market Share by Company in 2026
Figure 29. Passive Digital Biomarker Revenue by Company in 2026 ($ millions)
Figure 30. Global Passive Digital Biomarker Revenue Market Share by Company in 2026
Figure 31. Global Passive Digital Biomarker Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Passive Digital Biomarker Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 34. Americas Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 35. APAC Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 36. APAC Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 37. Europe Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 38. Europe Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Passive Digital Biomarker Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Passive Digital Biomarker Revenue 2021-2026 ($ millions)
Figure 41. Americas Passive Digital Biomarker Sales Market Share by Country in 2026
Figure 42. Americas Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Figure 43. Americas Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 44. Americas Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 45. United States Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Passive Digital Biomarker Sales Market Share by Region in 2026
Figure 50. APAC Passive Digital Biomarker Revenue Market Share by Region (2021-2026)
Figure 51. APAC Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 52. APAC Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 53. China Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 57. India Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Passive Digital Biomarker Sales Market Share by Country in 2026
Figure 61. Europe Passive Digital Biomarker Revenue Market Share by Country (2021-2026)
Figure 62. Europe Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 63. Europe Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 64. Germany Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 65. France Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Passive Digital Biomarker Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Passive Digital Biomarker Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Passive Digital Biomarker Sales Market Share by Application (2021-2026)
Figure 72. Egypt Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Passive Digital Biomarker Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Passive Digital Biomarker in 2026
Figure 78. Manufacturing Process Analysis of Passive Digital Biomarker
Figure 79. Industry Chain Structure of Passive Digital Biomarker
Figure 80. Channels of Distribution
Figure 81. Global Passive Digital Biomarker Sales Market Forecast by Region (2027-2032)
Figure 82. Global Passive Digital Biomarker Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Passive Digital Biomarker Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Passive Digital Biomarker Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Passive Digital Biomarker Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Passive Digital Biomarker Revenue Market Share Forecast by Application (2027-2032)
